Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Kenvue Inc.KVUE · Entity 3098 | Director | May 21, 2026 | May 26, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Kenvue Inc.
Report date May 21, 2026 · Filed May 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Share UnitsSEC Table II · derivative / convertible security | Direct | 56,975.45 |
Reported balance
After 2026-05-21 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-21 · Grant · Acquired 16,036 · Balance 56,975.45 F1: Grant of Deferred Share Units ("DSUs") under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date). F2: Includes DSUs acquired as dividend equivalents. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of Deferred Share Units ("DSUs") under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date).
F2: Includes DSUs acquired as dividend equivalents.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CVS HEALTH Corp
Report date May 31, 2021 · Filed June 02, 2021
Section 16 reporting ended · disclosed 2021-06-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 632,312.9407 |
Reported balance
After 2021-05-31 transaction · row 1
1 source rowRow 1 · 2021-05-31 · Tax withholding · Disposed 634 · Balance 632,312.9407 F1: Surrender of shares in payment of FICA taxes due upon retirement. |
Filing footnotes · ownership attribution and instrument terms
F1: Surrender of shares in payment of FICA taxes due upon retirement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 02, 2012 Filed Apr 4, 2012 20:03 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 332,736 | $45.07 Strike: $45.07 | $14,996,411.52 |
DisclosureSEC source: 0001127602-12-013293 · form4.xml · derivative · entry 6 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 332,736 Underlying: Common Stock · 332,736 shares Expires 2019-04-02 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/2/2013. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:03 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 83,204 | $45.07 | $3,750,004.28 |
DisclosureSEC source: 0001127602-12-013293 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288,004 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/2/2015 and 50% on 4/2/2017. Read SEC document |
| February 07, 2012 Filed Feb 9, 2012 22:07 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Unit | 43,500 | $43.08 | $1,873,980.00 |
DisclosureSEC source: 0001127602-12-004951 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 309,480.1657 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan, the receipt of which the reporting person has elected to defer. Read SEC document |
| May 12, 2011 Filed May 13, 2011 19:32 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 80,000 | $0.00 Strike: $12.56 | $0.00 |
DisclosureSEC source: 0001127602-11-016256 · form4.xml · derivative · entry 7 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 80,000 shares Expires 2013-01-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2011 Filed May 13, 2011 19:32 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 80,000 | $38.01 | $3,040,928.00 |
DisclosureSEC source: 0001127602-11-016256 · form4.xml · nonDerivative · entry 2 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,285.8541 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $38.00 and $38.05 per share. Read SEC document |
| May 12, 2011 Filed May 13, 2011 19:32 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 80,000 | $12.56 | $1,005,000.00 |
DisclosureSEC source: 0001127602-11-016256 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,285.8541 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 06, 2011 Filed Apr 8, 2011 20:02 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 144,822 | $0.00 Strike: $14.96 | $0.00 |
DisclosureSEC source: 0001127602-11-012779 · form4.xml · derivative · entry 7 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 144,822 shares Expires 2012-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 06, 2011 Filed Apr 8, 2011 20:02 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 144,822 | $36.00 | $5,214,200.25 |
DisclosureSEC source: 0001127602-11-012779 · form4.xml · nonDerivative · entry 2 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,285.8541 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · shares: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $36.00 and $36.08 per share. Read SEC document |
| April 06, 2011 Filed Apr 8, 2011 20:02 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 144,822 | $14.96 | $2,166,899.18 |
DisclosureSEC source: 0001127602-11-012779 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 292,107.8541 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 03, 2011 Filed Apr 5, 2011 20:15 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 3,091 | $34.96 | $108,061.36 |
DisclosureSEC source: 0001127602-11-012393 · form4.xml · nonDerivative · entry 2 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,285.8541 F2 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 01, 2011 Filed Apr 5, 2011 20:15 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 241,150 | $34.96 Strike: $34.96 | $8,430,604.00 |
DisclosureSEC source: 0001127602-11-012393 · form4.xml · derivative · entry 6 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,150 Underlying: Common Stock · 241,150 shares Expires 2018-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2012. Read SEC document |
| April 01, 2011 Filed Apr 5, 2011 20:15 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 64,360 | $34.96 | $2,250,025.60 |
DisclosureSEC source: 0001127602-11-012393 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,752 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse in two equal installments, 50% on 4/1/2014 and 50% on 4/1/2016. Read SEC document |
| January 03, 2011 Filed Jan 5, 2011 21:07 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 80,000 | $0.00 Strike: $12.56 | $0.00 |
DisclosureSEC source: 0001127602-11-001028 · form4.xml · derivative · entry 7 MERLO LARRY J · CIK 0001194413 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2013-01-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2011 Filed Jan 5, 2011 21:07 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 80,000 | $34.87 | $2,789,832.00 |
DisclosureSEC source: 0001127602-11-001028 · form4.xml · nonDerivative · entry 2 MERLO LARRY J · CIK 0001194413 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,051.6082 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $34.84 and $34.95 per share. Read SEC document |
| January 03, 2011 Filed Jan 5, 2011 21:07 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 80,000 | $12.56 | $1,005,000.00 |
DisclosureSEC source: 0001127602-11-001028 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,051.6082 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 06, 2010 Filed Dec 7, 2010 21:11 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 100,000 | $0.00 Strike: $22.45 | $0.00 |
DisclosureSEC source: 0001127602-10-029869 · form4.xml · derivative · entry 17 MERLO LARRY J · CIK 0001194413 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2012-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 06, 2010 Filed Dec 7, 2010 21:11 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 44,822 | $0.00 Strike: $14.96 | $0.00 |
DisclosureSEC source: 0001127602-10-029869 · form4.xml · derivative · entry 16 MERLO LARRY J · CIK 0001194413 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,822 Underlying: Common Stock · 44,822 shares Expires 2012-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 06, 2010 Filed Dec 7, 2010 21:11 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 96,700 | $0.00 Strike: $30.26 | $0.00 |
DisclosureSEC source: 0001127602-10-029869 · form4.xml · derivative · entry 15 MERLO LARRY J · CIK 0001194413 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 96,700 shares Expires 2011-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 06, 2010 Filed Dec 7, 2010 21:11 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 100,000 | $32.35 | $3,234,610.00 |
DisclosureSEC source: 0001127602-10-029869 · form4.xml · nonDerivative · entry 9 MERLO LARRY J · CIK 0001194413 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,051.6082 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $32.32 and $32.38 per share. Read SEC document |
| December 06, 2010 Filed Dec 7, 2010 21:11 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 100,000 | $22.45 | $2,244,500.00 |
DisclosureSEC source: 0001127602-10-029869 · form4.xml · nonDerivative · entry 8 MERLO LARRY J · CIK 0001194413 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,051.6082 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 06, 2010 Filed Dec 7, 2010 21:11 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 44,822 | $32.35 | $1,449,816.89 |
DisclosureSEC source: 0001127602-10-029869 · form4.xml · nonDerivative · entry 7 MERLO LARRY J · CIK 0001194413 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,051.6082 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $32.32 and $32.38 per share. Read SEC document |
| December 06, 2010 Filed Dec 7, 2010 21:11 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 44,822 | $14.96 | $670,649.18 |
DisclosureSEC source: 0001127602-10-029869 · form4.xml · nonDerivative · entry 6 MERLO LARRY J · CIK 0001194413 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,873.6082 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 06, 2010 Filed Dec 7, 2010 21:11 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 96,700 | $32.50 | $3,142,895.05 |
DisclosureSEC source: 0001127602-10-029869 · form4.xml · nonDerivative · entry 5 MERLO LARRY J · CIK 0001194413 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,051.6082 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $32.50 and $32.52 per share. Read SEC document |
| December 06, 2010 Filed Dec 7, 2010 21:11 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 96,700 | $30.26 | $2,926,383.75 |
DisclosureSEC source: 0001127602-10-029869 · form4.xml · nonDerivative · entry 4 MERLO LARRY J · CIK 0001194413 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,751.6082 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 03, 2010 Filed Dec 7, 2010 21:11 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 3,300 | $0.00 Strike: $30.26 | $0.00 |
DisclosureSEC source: 0001127602-10-029869 · form4.xml · derivative · entry 14 MERLO LARRY J · CIK 0001194413 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,700 Underlying: Common Stock · 3,300 shares Expires 2011-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 03, 2010 Filed Dec 7, 2010 21:11 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 3,300 | $32.50 | $107,250.00 |
DisclosureSEC source: 0001127602-10-029869 · form4.xml · nonDerivative · entry 3 MERLO LARRY J · CIK 0001194413 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,051.6082 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| December 03, 2010 Filed Dec 7, 2010 21:11 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 3,300 | $30.26 | $99,866.25 |
DisclosureSEC source: 0001127602-10-029869 · form4.xml · nonDerivative · entry 2 MERLO LARRY J · CIK 0001194413 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,351.6082 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2010 Filed Dec 7, 2010 21:11 UTC | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 2,860 | $34.83 | $99,613.80 |
DisclosureSEC source: 0001127602-10-029869 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,051.6082 Read SEC document |
| April 01, 2010 Filed Apr 5, 2010 22:06 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 152,988 | $0.00 Strike: $36.23 | $0.00 |
DisclosureSEC source: 0001127602-10-010564 · form4.xml · derivative · entry 6 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,988 Underlying: Common Stock · 152,988 shares Expires 2017-04-01 F2 · shares: Option becomes exercisable in three equal annual installments, commencing 4/1/2011. Read SEC document |
| April 01, 2010 Filed Apr 5, 2010 22:06 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 41,403 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-010564 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 289,834 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse on two equal installments 50% on 4/1/2013 and 50% on 4/1/2015. Read SEC document |
| February 17, 2010 Filed Feb 19, 2010 21:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Unit | 12,388 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-005630 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,366.1132 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 1997 Incentive Compensation Plan, the receipt of which the reporting person has elected to defer. Read SEC document |
| June 17, 2009 Filed Jun 19, 2009 19:51 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 100,000 | $0.00 Strike: $17.67 | $0.00 |
DisclosureSEC source: 0001127602-09-014320 · form4.xml · derivative · entry 9 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2011-01-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in three annual installments, commencing 1/3/2005. Read SEC document |
| June 17, 2009 Filed Jun 19, 2009 19:51 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 80,000 | $0.00 Strike: $19.28 | $0.00 |
DisclosureSEC source: 0001127602-09-014320 · form4.xml · derivative · entry 8 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 80,000 shares Expires 2010-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Option became exercisable in three annual instrallments, commencing 1/3/2002. Read SEC document |
| June 17, 2009 Filed Jun 19, 2009 19:51 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 100,000 | $17.67 | $1,766,750.00 |
DisclosureSEC source: 0001127602-09-014320 · form4.xml · nonDerivative · entry 3 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 325,911.6082 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2009 Filed Jun 19, 2009 19:51 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 80,000 | $19.28 | $1,542,504.00 |
DisclosureSEC source: 0001127602-09-014320 · form4.xml · nonDerivative · entry 2 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,911.6082 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2009 Filed Jun 19, 2009 19:51 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 180,000 | $31.06 | $5,591,646.00 |
DisclosureSEC source: 0001127602-09-014320 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,911.6082 Read SEC document |
| April 03, 2009 Filed Apr 7, 2009 20:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 3,165 | $28.45 | $90,044.25 |
DisclosureSEC source: 0001127602-09-008975 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,911.6082 F1 · shares: Surrender of shares in payment of withholding taxes due in connection with a previously reported transaction. Read SEC document |
| April 01, 2009 Filed Apr 3, 2009 20:15 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 185,572 | $0.00 Strike: $28.10 | $0.00 |
DisclosureSEC source: 0001127602-09-008760 · form4.xml · derivative · entry 6 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,572 Underlying: Common Stock · 185,572 shares Expires 2016-04-01 F2 · derivative.exercise_date: Option becomes exercisable in three equal annual installments, commencing 4/1/2010. Read SEC document |
| April 01, 2009 Filed Apr 3, 2009 20:15 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 46,264 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-09-008760 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,714 F1 · shares: Consists of Restricted Stock Units awarded pursuant to issuer's 1997 Incentive Compensation Plan. Restrictions lapse on two equal installments 50% on 4/1/2012 and 50% on 04/01/2014. Read SEC document |
| February 18, 2009 Filed Feb 20, 2009 21:07 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 20,549 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-09-004347 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,766 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 1997 Incentive Compensation Plan. Read SEC document |
| April 01, 2008 Filed Apr 3, 2008 20:30 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 144,144 | $0.00 Strike: $41.17 | $0.00 |
DisclosureSEC source: 0000064803-08-000045 · doc.xml · derivative · entry 17 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,144 Underlying: Common Stock · 144,144 shares Expires 2015-04-01 F6 · derivative.exercise_date: Option becomes exercisable in three equal annual installments, commencing 4/1/2009. Read SEC document |
| April 01, 2008 Filed Apr 3, 2008 20:30 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 121,448 | $0.00 | $0.00 |
DisclosureSEC source: 0000064803-08-000045 · doc.xml · nonDerivative · entry 3 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,450 F2 · shares: Consists of Restricted Stock Units awarded pursuant to issuer's 1997 Incentive Compensation Plan. Restrictions lapse on two equal installments 50% on 04/01/2011 and 50% on 04/01/2013. Read SEC document |
| April 01, 2008 Filed Apr 3, 2008 20:30 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 30,362 | $0.00 | $0.00 |
DisclosureSEC source: 0000064803-08-000045 · doc.xml · nonDerivative · entry 2 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,002 F2 · shares: Consists of Restricted Stock Units awarded pursuant to issuer's 1997 Incentive Compensation Plan. Restrictions lapse on two equal installments 50% on 04/01/2011 and 50% on 04/01/2013. Read SEC document |
| February 12, 2008 Filed Feb 14, 2008 21:52 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Unit | 14,494 | $0.00 | $0.00 |
DisclosureSEC source: 0000064803-08-000023 · doc.xml · nonDerivative · entry 3 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,648.9257 F2 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 1997 Incentive Compensation Plan, the receipt of which the reporting person has elected to defer. Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 20:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 200,000 | $0.00 Strike: $18.66 | $0.00 |
DisclosureSEC source: 0000064803-07-000141 · doc.xml · derivative · entry 19 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 200,000 shares Expires 2008-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Option became exercisable in three annual installments, commencing 03/12/01. Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 20:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 130,440 | $0.00 Strike: $18.35 | $0.00 |
DisclosureSEC source: 0000064803-07-000141 · doc.xml · derivative · entry 18 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 130,440 shares Expires 2008-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Option became exercisable in three annual installments, commencing 02/27/01. Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 20:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 330,440 | $37.46 | $12,379,141.54 |
DisclosureSEC source: 0000064803-07-000141 · doc.xml · nonDerivative · entry 3 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,267 F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 20:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 200,000 | $18.66 | $3,731,260.00 |
DisclosureSEC source: 0000064803-07-000141 · doc.xml · nonDerivative · entry 2 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 464,707 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 20:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 130,440 | $18.35 | $2,393,273.99 |
DisclosureSEC source: 0000064803-07-000141 · doc.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,707 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| April 02, 2007 Filed Apr 4, 2007 21:24 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 136,089 | $0.00 Strike: $34.42 | $0.00 |
DisclosureSEC source: 0000064803-07-000079 · doc.xml · derivative · entry 17 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,089 Underlying: Common Stock · 136,089 shares Expires 2014-04-02 F6 · derivative.exercise_date: Option becomes exercisable in three equal annual installments, commencing 4/2/2008. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.